Welcome to our dedicated page for Grayscale Chainlink Trust ETF SEC filings (Ticker: GLNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Grayscale Chainlink Trust ETF filings document the regulatory record for a Grayscale-sponsored digital-asset trust with an Index Price based on the CoinDesk Chainlink Benchmark Rate. Registration statements describe the Trust’s securities offering framework, Delaware trust organization, sponsor role, and disclosures around the Chainlink market and index methodology.
Current reports on Form 8-K record material events such as changes to the constituent trading platforms and LINK-USD or LINK-USDC pairs used in the benchmark rate, as well as sponsor communications policies involving cashtags and third-party content on X. The filings are signed on behalf of the Trust by an authorized officer of Grayscale Investments Sponsors, LLC.
Grayscale Chainlink Trust (LINK) filed Amendment No. 1 to a Form S-1 to register an indeterminate number of Shares and list on NYSE Arca under the symbol GLNK, issuing Shares on a continuous basis after effectiveness.
Shares are created and redeemed in Baskets of 10,000 Shares. At this time, creations and redemptions occur via Cash Orders facilitated by Liquidity Providers; in‑kind transactions with Authorized Participants may occur only if NYSE Arca obtains In‑Kind Regulatory Approval. Upon creations, the Trust receives LINK, which may be used to pay expenses, support redemptions, or, if the Staking Condition is satisfied in the future, for staking.
The Trust targets NAV tracking based on a CoinDesk LINK reference rate and operates as an emerging growth company. The Sponsor’s Fee accrues at 0.35% of the NAV fee basis amount, with a stated waiver through the earlier of three months from initial NYSE Arca listing or reaching $1 billion in AUM. Risk factors emphasize digital asset volatility, regulatory uncertainty, potential premiums/discounts to NAV, and the current lack of in‑kind creations and staking.
GLNK filed a Form 144 notice for a proposed sale of restricted/affiliate securities. The filing lists 640 common shares to be sold with an aggregate market value of $13,888, through Canaccord Genuity Corp. The approximate sale date is 11/06/2025, and the shares are listed on the OTCQB. Shares outstanding were 1,453,100.
The seller reported prior sales during the past three months, including 1,500 shares on 10/24/2025 for $41,782.05 and 1,400 shares on 11/05/2025 for $32,354.00. The securities to be sold were acquired in a privately negotiated transaction from the issuer on 06/24/2021 for cash.
GLNK filed a Form 144 notice for a proposed sale of restricted securities. The filer indicates an intent to sell 1,400 common shares through Canaccord Genuity Corp with an aggregate market value $32,354, targeting an approximate sale date of 11/05/2025 on the OTCQB.
The securities to be sold were acquired on 06/24/2021 via a privately negotiated transaction from the issuer, with payment made in cash. The filing also lists recent sales over the past three months by DCG International Investments Ltd, including 1,500 shares on 10/24/2025 for $41,782.05 and 1,200 shares on 08/05/2025 for $30,312.00. These entries document historical sales activity alongside the new proposed sale.
GLNK filed a Form 144 notice for a proposed sale of restricted/common shares under Rule 144. The filing lists a planned sale of 1,331 common shares with an aggregate market value of $30,687.14. The approximate sale date is 11/05/2025, with trading on OTCQX through Capital Institutional Services, Inc.
Securities outstanding were 1,453,100 shares as of the filing’s context. The seller previously sold 1,333 shares on 07/25/2025 for $46,532.00 in gross proceeds. The filing also notes the shares were acquired in privately negotiated transactions from the issuer on 08/06/2021 (458 shares) and 02/22/2024 (2,960 shares), paid in cash.
Form 144 alerts the market to a holder’s intent to sell restricted or control securities in compliance with Rule 144. Proceeds from any sales would go to the selling holder.
GLNK: DCG International Investments Ltd filed a Form 144 to sell 750 common shares through Canaccord Genuity on the OTCQB, with an aggregate market value of $16,545.00 and an approximate sale date of November 4, 2025. The shares were originally acquired on June 24, 2021 in a privately negotiated, cash transaction from the issuer.
Shares outstanding were 1,453,100 as of the filing excerpt. The filer also reported recent sales in the past three months, including 1,500 shares on October 24, 2025 for $41,782.05 and 1,200 shares on August 5, 2025 for $30,312.00.
GLNK: DCG International Investments Ltd filed a Form 144 notice for a proposed sale of common stock. The filing lists up to 1,300 shares with an aggregate market value of $29,770 to be sold through Canaccord Genuity Corp, with an approximate sale date of 11/03/2025 on the OTCQB.
Shares outstanding were 1,453,100. The seller reported prior sales in the past three months, including 1,500 shares on 10/24/2025 for $41,782.05 and 1,300 shares on 10/27/2025 for $38,831. The 1,300 shares to be sold were originally acquired on 06/24/2021 in a privately negotiated transaction from the issuer for cash.
DCG International Investments Ltd filed a Form 144 notice to sell up to 1,300 shares of GLNK common stock. The filing lists Canaccord Genuity Corp as broker, an aggregate market value of 31,629.00, an approximate sale date of 10/31/2025, and the OTCQB as the trading venue.
Shares outstanding were 1,453,100. The seller reports prior sales within the past three months, including 1,500 shares on 10/24/2025 for gross proceeds of 41,782.05 and 1,300 shares on 10/27/2025 for gross proceeds of 38,831.0. The 1,300 shares to be sold were acquired on 06/24/2021 in a privately negotiated purchase from the issuer for cash.
GLNK: A holder filed a Form 144 notice to sell 1,300 shares of common stock with an aggregate market value of $31,070. The planned sale is listed for October 30, 2025 on the OTCQB, with Canaccord Genuity Corp as broker.
The shares to be sold were acquired on June 24, 2021 in a privately negotiated transaction from the issuer for cash. Shares outstanding are reported as 1,453,100; this is a baseline figure, not the amount being sold. The filer also reports prior sales in the past three months, including 1,500 shares on October 24, 2025 for gross proceeds of $41,782.05.
GLNK: A selling stockholder filed a Form 144 to sell 1,300 shares of common stock through Canaccord Genuity Corp. The filing lists an aggregate market value of $33,527.00 for the proposed sale, with 1,453,100 shares outstanding and an approximate sale date of 10/29/2025 on the OTCQB.
The shares were originally acquired on 06/24/2021 in a privately negotiated transaction from the issuer for cash. The filer also reported recent sales over the past three months by DCG International Investments Ltd, including 1,500 shares on 10/24/2025 and 1,300 shares on 10/27/2025.
GLNK: A selling stockholder filed a Form 144 to sell 1,300 shares of common stock with an aggregate market value of $35,464, with an approximate sale date of 10/28/2025.
The planned sale lists Canaccord Genuity Corp as broker and the OTCQB as the trading venue. Shares outstanding were 1,453,100 as of the notice; this is a baseline figure, not the amount being sold.
The shares were acquired on 06/24/2021 in a privately negotiated transaction from the issuer for cash. The notice also reports prior sales in the last three months, including 1,500 shares on 10/24/2025 for gross proceeds of $41,782.05 and 1,300 shares on 10/27/2025 for $38,831.00.